Global
Sinus Dilation Devices Market, By Product (Balloon Dilation, Stents,
Endoscope (Rhinoscopy, Sinoscopy), Handheld), Procedure (Standalone, Hybrid),
Patient Type (Adult, Pediatric), Patient Care Setting (Ear, Nose Throat(ENT)
Clinic, Hospitals, Ambulatory Surgical Centers), Geography (North America,
South America, Europe, Asia-Pacific, Middle East And Africa) - Forecast to 2025
Market Analysis: Global Sinus Dilation Devices Market
The Global Sinus Dilation Devices
Market is expected to reach USD 7343.89 billion by 2025, from USD 3631.9
million in 2017 growing at a CAGR of 9.2% during the forecast period of 2018 to
2025. The upcoming market report contains data for historic year 2016, the base
year of calculation is 2017 and the forecast period is 2018 to 2025.
Download PDF Sample Copy of this Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-sinus-dilation-devices-market
Major Market Competitors/Players:
·
Entellus Medical Inc. (a subsidiary of Stryker)
(US),
·
Acclarent Inc. (a subsidiary of Johnson &
Johnson) (US),
·
Medtronic plc (Ireland),
·
Smith & Nephew plc (UK),
·
Intersect ENT Inc. (US),
·
Olympus Corporation (Japan),
·
Meril Life Sciences Pvt. Ltd. (India),
·
SinuSys Corporation (US),
·
InAccel (India),
·
Jilin Coronado Medical Ltd. (China),
·
Sklar Surgical Instruments,
·
Bausch & Lomb Incorporated,
·
Creganna Medical (Ireland),
·
Among others
Competitive Analysis:
The global sinus
dilation devices market is highly fragmented and the major players have
used various strategies such as new product launches, expansions, agreements,
joint ventures, partnerships, acquisitions, and others to increase their
footprints in this market. The report includes market shares of global sinus
dilation devices market for global, Europe, North America, Asia Pacific and
South America.
Market Definition:
This market report defines the
market trends and forecast the upcoming opportunities and threats of the global
sinus dilation devices market in the next 8 years.
Sinusitis is a disorder which is
classified by inflammation with sinus lining which causes mucus drainage and
nose blockage. Sinus dilation devices used to open up the sinus lining of
patients suffering from mucus drainage and sinusitis.
Balloon sinus dilation is one of
the advanced procedures. It is slightly invasive technique that substitutes the
traditional sinus surgeries process. During this process, doctor redesigns the
patient’s sinus path with inflated balloons to open the congested sinus or
nasal pathway.
According to the Royal Australian
College of General Practitioners, in 2011 and 2012, an estimated 1.9 million
Australians had chronic rhinosinusitis and 1.4 in every 100 general practice
encounters were for acute or chronic sinusitis.
According to the Centers for
Disease control and preventions (CDC), 26.9 million adults were diagnosed with
sinusitis which is around 11.0%.
Avail the exclusive Discount offer @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-sinus-dilation-devices-market
Drivers and Restraints:
·
High prevalence of chronic sinusitis
·
Increase in patient preference for minimally
invasive surgeries
·
Growth in awareness about sinusitis surgeries
·
incidence of post-operative risks after sinus
surgeries
·
Low adoption of sinus treatment devices
·
Owing to increased preference for drugs
Market Segmentation:
·
Balloon Dilation
·
Stents
·
Endoscope and Handheld
Based on procedure:
·
Standalone
·
Hybrid
Based on patient type:
·
Adults
·
Pediatric
Based on patient care setting:
·
Ear
·
Nose Throat(ENT) Clinic
·
Hospitals
·
Ambulatory Surgical Centers
Based on geography:
·
North America
·
South America
·
Europe
·
Asia-Pacific
·
Middle East & Africa
Some of the major countries
covered in this report are U.S., Canada, Germany, France, U.K., Netherlands,
Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia,
Singapore, South Africa and, Brazil among others. In 2017, North America is
expected to dominate the market.
Key Developments in the Market:
In December 2016, Sanovas, Inc.
(USA), announced launch of its wholly-owned subsidiary, SinuGeniX, Inc. and its
RegENT Sinus Treatment System. The RegENT Sinus Treatment System (STS) is
planned to advance sinus surgery by providing quicker contact with controlled
anesthetization and drug delivery.
In December 2017, Intersect ENT,
Inc. (U.S.) announced the U.S. FDA approval of SINUVA (mometasone furoate)
Sinus Implant. SINUVA is approach for the treatment of nasal polyp infection in
patients who had ethmoid sinus surgery before.
View Full Report @ https://databridgemarketresearch.com/reports/global-sinus-dilation-devices-market/
About Us:
Data Bridge Market Research
set forth itself as an unconventional and neoteric Market research and
consulting firm with unparalleled level of resilience and integrated
approaches. We are determined to unearth the best market opportunities and
foster efficient information for your business to thrive in the market. Data
Bridge endeavors to provide appropriate solutions to the complex business
challenges and initiates an effortless decision-making process.
Data Bridge adepts in creating
satisfied clients who reckon upon our services and rely on our hard work with
certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818